Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus

Secondary immune damage to the intestinal mucosa due to an influenza virus infection has gained the attention of investigators. The protection of the intestinal barrier is an effective means of improving the survival rate in cases of severe pneumonia. We developed a fusion protein, Vunakizumab-IL22(...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chenchen, Su, Chang, Cen, Lifeng, Han, Lei, Tang, Jianguo, Wang, Zetian, Shi, Xunlong, Ju, Dianwen, Cao, Yiou, Zhu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135487/
https://www.ncbi.nlm.nih.gov/pubmed/37189778
http://dx.doi.org/10.3390/biomedicines11041160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135487/
https://www.ncbi.nlm.nih.gov/pubmed/37189778
http://dx.doi.org/10.3390/biomedicines11041160

Ejemplares similares